Early stage IT and Healthcare Investing

Xenon Pharmaceuticals


company snapshot

Xenon Pharmaceuticals

Xenon (XENE) is a clinical genetics-based drug development company. Independently and through partnerships with leading global pharmaceutical companies, Xenon identifies and validates new targets for drug development and converts that knowledge into innovative and differentiated medicines. Its programs focus on indications of important unmet medical needs, including pain, anemia, iron overload, metabolic and cardiovascular disease.

Follow The Company
Investment Team
Simon Pimstone, President & CEO
Facebook Google+ Twitter Email LinkedIn Share